Sourcing guide · research use only
Where to buy CJC-1295 for research.
CJC-1295 is a modified GHRH (1-29) analog studied in laboratory research — and the single most-confused thing about sourcing it is DAC vs no-DAC: two different research compounds sold under one name. This guide covers how to confirm which one a listing is actually selling, what a real certificate of analysis should show, why CJC-1295 is so often paired with Ipamorelin, and how Titan fulfills research orders. It makes no human-use, dosing, or efficacy claims.
Before you buy
What a CJC-1295 COA must prove.
A CJC-1295 document has to do everything a peptide COA does — and then settle the DAC question before you trust anything else on it. Run any CJC-1295 listing against this table before you buy.
| What to check | What a real COA shows | Red flag |
|---|---|---|
| DAC vs no-DAC identity | The COA names the exact compound — CJC-1295 with DAC (drug affinity complex) or CJC-1295 without DAC (Mod GRF 1-29) — so you know which research peptide you received | A listing that just says "CJC-1295" with no DAC status — the most common labeling gap on this peptide |
| Sequence identity (MS) | Mass spectrometry confirming the modified GHRH (1-29) sequence — the baseline any peptide COA should carry | A purity number with no identity test, so the sequence is unverified |
| Purity (HPLC) | An HPLC chromatogram with the trace shown, not just a percentage | A bare percentage with no chromatogram to read |
| Blend ratio (if pre-mixed) | For a CJC-1295 + Ipamorelin blend, the amount of each compound in the vial, separately verified | A combined "total mg" with no breakdown of GHRH analog vs GHRP |
| Lot / batch + compliance | A lot code matching the vial, documentation silent on human use | A generic reused COA, mismatched lot, or human-use / dosing claims |
DAC vs no-DAC is the whole question
CJC-1295 is studied in two forms that share a name but behave differently in research: CJC-1295 with DAC (a drug affinity complex that extends its presence by binding serum albumin) and CJC-1295 without DAC, often listed as Mod GRF 1-29. They are not interchangeable, and a listing that just says "CJC-1295" has not told you which one is in the vial. Before anything else, confirm the DAC status on the certificate of analysis — not just in the marketing copy.
CJC-1295 research guide →What a CJC-1295 COA should prove
Beyond naming DAC or no-DAC, a CJC-1295 certificate of analysis should confirm the modified GHRH (1-29) sequence by mass spectrometry and report purity with an HPLC chromatogram you can actually read — not just a number. If the vial is a pre-blended CJC-1295 + Ipamorelin product, the document should account for both compounds, since a GHRH analog and a GHRP are two separate research peptides in one vial.
How to read a COA →Why it's usually paired with a GHRP
In the research literature, GHRH analogs like CJC-1295 are frequently studied alongside growth-hormone-releasing peptides such as Ipamorelin — two different receptor pathways examined together. That is why CJC-1295 is so often sourced as a pre-mixed blend rather than alone. If you are buying a blend, the same rule applies twice: verify the identity and amount of each compound, not just a single combined figure.
Secretagogue vs GHRP →What to verify before buying CJC-1295
Before you buy, confirm a lot-matched third-party COA that states the DAC status, confirms the sequence by mass spectrometry, backs purity with a chromatogram, breaks down any blend ratio, and matches the lot number on the vial — all under research-use-only labeling. Reconstitute and store the lyophilized peptide per the supplier's release sheet as a research material; the documentation, not a usage instruction, is what you verify at purchase.
What a documented supplier looks like →Red flags on CJC-1295 listings
Walk away from any CJC-1295 source whose documentation carries human-use, dosing, or efficacy claims — that is a compliance red flag, not a quality spec. Be skeptical of a listing that never states DAC vs no-DAC, a COA with a purity percentage but no chromatogram, a blend that reports only a combined milligram total, a single generic document reused across products, or a lot code that doesn't match the vial.
Sourcing research compounds →How Titan fulfills CJC-1295 research orders
DAC status named, blend verified, crypto checkout.
- 1. Know which compound you're buying. Titan's CJC-1295 is supplied pre-blended with Ipamorelin in a single lyophilized vial; the documentation accounts for the GHRH analog and the GHRP separately rather than as one combined figure.
- 2. Lot-matched documentation. Each order ships referenced to a batch code, with an HPLC purity target and identity confirmation by mass spectrometry.
- 3. Crypto-only checkout. USDC, BTC, and SOL accepted; stablecoin keeps the total fixed from cart to on-chain confirmation.
- 4. Verify it yourself. Match the lot code to the vial and check the COA accounts for both compounds in the blend — not just a single total.
CJC-1295 is a modified growth-hormone-releasing-hormone analog studied in laboratory research, frequently alongside growth-hormone-releasing peptides such as Ipamorelin. Titan supplies it strictly for research use only and makes no human-use, dosing, or efficacy claims. This page is about sourcing and verification, not use.